---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-031028"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2026-08-04T10:01:26+00:00"
generated_at: "2026-08-04T10:10:58.720882+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lisata Therapeutics cuts 72% of workforce, sues Kuva Labs over merger breach

## Summary
- Workforce reduced by ~72% effective immediately; estimated $1.2M in severance costs through Q3 2026.
- CMO Dr. Kristen K. Buck terminated without cause; entitled to 12 months salary and bonus plus COBRA.
- Company sued Kuva Labs in Delaware Chancery for breach of March 2026 merger agreement, seeking damages.
- Retention bonus of $200k approved for SVP James Nisco, contingent on employment through Dec 31, 2026.
- Company plans to pursue strategic options to maximize shareholder value.

## SEC filing metadata
- accession: 0001140361-26-031028
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2026-08-04T10:01:26+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000114036126031028/0001140361-26-031028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000114036126031028/ef20079399_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-031028
- JSON: https://secwatch.observer/filing/0001140361-26-031028.json
- Plain text: https://secwatch.observer/filing/0001140361-26-031028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.